Fig. 9From: ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathwayApoE4 downregulates ACE2 protein expression and consequently decreases the conversion of Ang II to Ang 1–7, which may contribute to adverse COVID-19 outcomesBack to article page